Prolacta Bioscience

Prolacta Bioscience is a biotechnology startup founded in 1999 and headquartered in the United States. The company's slogan, "Advancing the science of human milk," reflects its dedication to revolutionizing neonatal care. Prolacta Bioscience focuses on bringing the healing power of breast milk to critically ill infants in neonatal care, with a specific emphasis on preemies. Their human milk-based neonatal nutritional products are changing the standard of care in hospitals nationwide. The last recorded investment for Prolacta Bioscience was a significant $8.91M Venture Round investment on 15 May 2018. Despite the absence of specific investors listed in the provided data, this investment demonstrates a continued interest in the company's mission and potential for growth. Prolacta Bioscience's commitment to leveraging the science of human milk for the betterment of neonatal care positions the company at the intersection of healthcare and biotechnology. The direct impact of their products on critically ill infants in hospitals underscores the company's potential to create meaningful change and potentially attract further investments. For more information and to connect with Prolacta Bioscience, one can visit their website at www.prolacta.com and engage with them on social media platforms such as Facebook (@prolacta), Twitter (@prolacta), and Instagram (@prolacta_bioscience). These channels provide insights into the company's activities and potential future developments.